As of mid-2026, Indiana Medicaid (operated through the Healthy Indiana Plan, or HIP) does not cover GLP-1 medications for obesity specifically
A faster and safer approach: Give 40 mEq of oral potassium chloride it can raise serum K within about 1 hour
GLP-1 Medications and Gastroparesis: Understanding a Serious Side Effect Category: Southwest General Medical Group, Women's Health, Gastroenterology, General Health, Family Medicine, Endocrinology, Diabetes & Metabolism, Men's Health, Diet Posted On: GLP-1 medications, such as Ozempic and Wegovy, have helped many people manage type 2 diabetes and achieve significant weight loss
External resources New England Journal of Medicine: Retatrutide Phase 2 trial results PMC meta-analysis: Comparative efficacy of GLP-1 receptor agonists Nature Medicine: Retatrutide for MASLD randomized Phase 2a trial Eli Lilly: TRIUMPH-4 Phase 3 retatrutide results press release New England Journal of Medicine: Tirzepatide versus semaglutide head-to-head trial In case I do not see you, good afternoon, good evening, and good night
Cai X, She M, Xu M, Chen H, Li J, Chen X, et al
